A. Buntinx
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Urology top 5%
Papers in
-
- Sexual Differentiation and Disorders 4
-
- Inflammatory mediators and NSAID effects 3
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Wesley Tanaka (4 shared papers)Inge De Lepeleire (6 shared papers)P.J. De Schepper (7 shared papers)Anne Van Hecken (7 shared papers)Marleen Depré (4 shared papers)Jonathan A. Tobert (3 shared papers)Vito Angelo Giagulli (2 shared papers)P. De Schepper (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (5 papers)European Journal of Clinical Pharmacology (2 papers)European Urology (1 paper)The Prostate (1 paper)Eye (1 paper)
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
A. Buntinx
23 papers receiving 924 citations
Peers
Comparison fields: 5 of 95
- Pharmacology 307
- Pharmacology 105
- Urology 64
- Biochemistry 69
- Immunology and Allergy 49
Countries citing papers authored by A. Buntinx
This map shows the geographic impact of A. Buntinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Buntinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Buntinx more than expected).
Fields of papers citing papers by A. Buntinx
This network shows the impact of papers produced by A. Buntinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Buntinx. The network helps show where A. Buntinx may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Buntinx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 285 | |
| 2 | 1982 | 173 | |
| 3 | 1993 | 126 | |
| 4 | 1989 | 87 | |
| 5 | 1991 | 55 | |
| 6 | 1981 | 53 | |
| 7 | 1991 | 28 | |
| 8 | 1981 | 24 | |
| 9 | 1991 | 22 | |
| 10 | 1980 | 19 | |
| 11 | 1993 | 18 | |
| 12 | 1992 | 18 | |
| 13 | 2011 | 16 | |
| 14 | 1987 | 12 | |
| 15 | 1978 | 10 | |
| 16 | 1986 | 7 | |
| 17 | 1992 | 7 | |
| 18 | 1992 | 6 | |
| 19 | Lack of interaction between famotidine and warfarin. | 1990 | 6 |
| 20 | 1999 | 6 |
About A. Buntinx
A. Buntinx is a scholar working on Molecular Biology, Pharmacology, Endocrinology, Diabetes and Metabolism, Physiology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 990 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (6 papers), Hormonal and reproductive studies (5 papers), Sexual Differentiation and Disorders (4 papers), Inflammatory mediators and NSAID effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Respiratory and Cough-Related Research (3 papers) and Inhalation and Respiratory Drug Delivery (2 papers). The work is most often cited by research in Pharmacology (307 citations), Pharmacology (105 citations), Urology (64 citations), Biochemistry (69 citations) and Immunology and Allergy (49 citations). A. Buntinx has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Wesley Tanaka, Inge De Lepeleire, P.J. De Schepper, Anne Van Hecken, Marleen Depré, Jonathan A. Tobert, Vito Angelo Giagulli, P. De Schepper, Ian Holmes and A. Vermeulen. Their work appears in journals such as Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, European Urology, The Prostate and Eye.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.